Clinical Trials
2 trialsNCT05481775 2022-11-21
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Withdrawn
NCT03371550 2017-12-13
TAXCIS
Centre Antoine Lacassagne
Phase 2 Completed